Metadata about: Data-driven AI promises support for pathologists to discover sparse tumor patterns in high-resolution histological images. However, three limitations prevent AI from being adopted into clinical practice: (i) a lack of comprehensiveness where most AI algorithms only rely on single criteria/examination; (ii) a lack of explainability where AI models work as 'black-boxes' with little transparency; (iii) a lack of integrability where it is unclear how AI can become part of pathologists' existing workflow. To address these limitations, we propose CrossPath: a brain tumor grading tool that supports top-down, cross data type, multi-criterion histological analysis, where pathologists can shepherd mixed AI models. CrossPath first uses AI to discover multiple histological criteria with H and E and Ki-67 slides based on WHO guidelines. Second, CrossPath demonstrates AI findings with multi-level explainable supportive evidence. Finally, CrossPath provides a top-down shepherding workflow to help pathologists derive an evidence-based, precise grading result. To validate CrossPath, we conducted a user study with pathologists in a local medical center. The result shows that CrossPath achieves a high level of comprehensiveness, explainability, and integrability while reducing about one-third time consumption compared to using a traditional optical microscope.

About: Data-driven AI promises support for pathologists to discover sparse tumor patterns in high-resolution histological images. However, three limitations prevent AI from being adopted into clinical practice: (i) a lack of comprehensiveness where most AI algorithms only rely on single criteria/examination; (ii) a lack of explainability where AI models work as 'black-boxes' with little transparency; (iii) a lack of integrability where it is unclear how AI can become part of pathologists' existing workflow. To address these limitations, we propose CrossPath: a brain tumor grading tool that supports top-down, cross data type, multi-criterion histological analysis, where pathologists can shepherd mixed AI models. CrossPath first uses AI to discover multiple histological criteria with H and E and Ki-67 slides based on WHO guidelines. Second, CrossPath demonstrates AI findings with multi-level explainable supportive evidence. Finally, CrossPath provides a top-down shepherding workflow to help pathologists derive an evidence-based, precise grading result. To validate CrossPath, we conducted a user study with pathologists in a local medical center. The result shows that CrossPath achieves a high level of comprehensiveness, explainability, and integrability while reducing about one-third time consumption compared to using a traditional optical microscope.

an Entity references as follows:

Graph IRI	Count
http://ns.inria.fr/covid19/graph/entityfishing	3
http://ns.inria.fr/covid19/graph/articles	3

Faceted Search & Find service v1.13.91

This work is licensed under a Creative Commons Attribution-Share Alike 3.0 Unported License.
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Copyright © 2009-2025 OpenLink Software